( May 5, 2026, 1:10 PM EDT) -- WASHINGTON, D.C. — Manufacturers of spinal cord stimulators tell the U.S. Judicial Panel on Multidistrict Litigation (JPMDL) that it should reject efforts to centralize all pending cases against Abbott Laboratories and Boston Scientific Corp. brought by individuals who allege that they were injured by defective spinal cord stimulators and deny certain plaintiffs’ efforts to expand the scope of the MDL to include claims against them....